Study of the Effects of Nebivolol Intervention on Outcomes and Rehospitalisation in Seniors with Heart Failure (SENIORS). Rationale and design.
Shibata
Marcelo C
MC
Clinical Trials and Evaluation Unit, Royal Brompton and Harefield NHS Trust, London, UK
Flather
Marcus D
MD
Böhm
Michael
M
Borbola
Josef
J
Cohen-Solal
Alain
A
Dumitrascu
Daniel
D
Ferrari
Roberto
R
Lechat
Philippe
P
Parkhomenko
Alexander
A
Soler-Soler
Jordi
J
Tavazzi
Luigi
L
Toman
Jiri
J
Van Veldhuisen
Dirk J
DJ
Coats
Andrew J S
AJ
Poole-Wilson
Philip
P
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000368:Aged; D001578:Benzopyrans / Q000627:therapeutic use*; D017326:Clinical Trials, Phase III as Topic; D004311:Double-Blind Method; D004983:Ethanolamines / Q000627:therapeutic use*; D006333:Heart Failure / Q000188:drug therapy*; D006760:Hospitalization; D006801:Humans; D015337:Multicenter Studies as Topic; D000068577:Nebivolol; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic; D012107:Research Design; D016896:Treatment Outcome; D014665:Vasodilator Agents / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D001578:Benzopyrans; D004983:Ethanolamines; D014665:Vasodilator Agents; D000068577:Nebivolol